Navigation Links
InterMune Reports Second Quarter 2014 Financial Results and Business Highlights
Date:8/6/2014

or 2014.  All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information.  InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Other factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on February 24, 2014 (the "Form 10-K") and other periodic reports filed with the SEC, including but not limited to the following: (i) the risks related to the uncertain, lengthy and expensive clinical development process for the company's product candidates, including having no unexpected safety, toxicology, clinical or other issues and having no unexpected clinical trial results such as unexpected new clinical data and unexpected additional analysis of existing clinical data; (ii) risks related to the regulatory process for the company's product candidates, including the possibility that the results of the new 52-week Phase 3 clinical trial (ASCEND) having an FVC endpoint may not be satisfactory to the FDA for InterMune to receive regulatory approval for pirfenidone in the United States; (iii) risks related to unexpected regulatory actions or delays or government regulation generally; (iv) risks related to the company's manufacturing strategy, which relies on third-party manufacturers and which exposes InterMune to additional risks where it may lose potential revenue; (v) government, industry and general public pricing pressures; (vi) risks related to our ability to successfully launch and commercialize Esbriet in Europe and Canada, including successfully establishing a commercial operation in Europe and Canada an
'/>"/>

SOURCE InterMune, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
4. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
5. InterMune Announces Presentations of New Research in IPF at ERS
6. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
7. InterMune to Divest Actimmune® (Interferon Gamma-1b)
8. Neurocrine Biosciences Reports Second Quarter 2014 Results
9. Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
10. China Biologic Reports Financial Results for the Second Quarter of 2014
11. Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Wash. , Oct. 30, 2014   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... third quarter 2014 financial results will be released on ... host a conference call and live webcast at 1:30 ...
(Date:10/30/2014)... -- , Extensively hydrolyzed milk formula with LGG ... Cow milk protein allergy (CMPA) is the leading cause of food ... has been managed by eliminating milk proteins from a ... is possible to help build of oral tolerance to ... the first year of life by using an extensively ...
(Date:10/30/2014)... , Oct. 29, 2014 Electrodes are ... which can be amplified to diagnose as well ... used in medical devices facilitate the detection of ... muscle cells and neurons of the patients. In ... the radiofrequency alternating current to perform minimally invasive ...
Breaking Medicine Technology:BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 2Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 3Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 4
... 01, 2007 /PRNewswire-FirstCall/ --,EntreMed, Inc. , a ... of cancer and inflammatory diseases,announced the presentation ... angiogenesis inhibitor, ENMD-981693. The data were,presented during ... the 2nd Protein Kinases in Drug Discovery ...
... 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today,announced that the ... SNS-595 and SNS-032 at the 12th Congress of ... 2007 in Vienna,Austria. , Presentations will include updated ... of SNS-595 in acute leukemias, as,well as clinical ...
Cached Medicine Technology:EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 2EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 3Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3
(Date:10/30/2014)... the DFG Research Center for Regenerative Therapies Dresden - ... for the first time the in vitro growth of ... mouse embryonic stem cells. Correct spatial organization of motor ... was observed., This study has been published online by ... on 30.10.2014 ., For many years Elly Tanaka and ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Nutrition Leaders, ... supplements, weight loss aids, and more, is currently hosting ... which is already underway, is open to U.S. residents ... on December 15, 2014. One lucky winner will then ... receive a $100 gift card to NutritionLeaders.com. , Nutrition ...
(Date:10/30/2014)... 2014 Graphics, coding, typography and search ... the craft of web design and require thorough knowledge ... simpler solution to create a website can be as ... information, customer reviews and Facebook posts all accumulate on ... the next evolution of how a business can develop ...
(Date:10/30/2014)... Calif. (PRWEB) October 30, 2014 ... mutually exclusive concepts in the medical-grade skin care ... the development of uniquely potent topical dermatological products, ... System ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant ... glycolic acid concentrations (50% and 70%) and a ...
(Date:10/30/2014)... PreDiabetes Centers , the pioneer in ... with a supply of sugardown®, a chewable dietary supplement ... sugar spikes. Learning how to control blood sugar levels ... a diabetes prevention plan. , Shoppers who spend $50 ... of sugardown. The offer expires November 30. , ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Facebook Websites In Thirty-Seconds 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2
... ... will attend. , ... 15, 2010 -- The 8th annual Go Skateboarding Day (GSD), celebrated annually on ... around the world are celebrating all weekend long. , ,GSD unites the global skateboard ...
... Oregon State University uses the snapshot-in-time miracle of amber to ... plant fossils not just what ancient life forms looked ... moment of death. All kinds of behavior, ranging from ... to the behavior of pathogenic microbes can be observed in ...
... ... one of the nation’s fastest growing Medical Management companies specializing in Emergency Department ... Hospital Physician Partners newest Emergency Department (ED) contract in Pennsylvania., , ... Ft. Lauderdale, Florida ...
... Preclinical findings recently published in Cancer Research ... Research, showed RG7204 (PLX4032) inhibited proliferation of tumor cell ... human cancers, including melanoma. The compound also ... in a dose-dependent manner in preclinical efficacy models in ...
... are more likely to underestimate their preschool children,s weight ... overweight or gaining weight too fast, a study by ... reports. The study, published online earlier ... should not hesitate to wield their influence in helping ...
... Summertime ... beneath the summer sun. Health care providers at the VA Maryland Health Care System ... ... brings outside games, yard work, camping, swimming, trips to the beach, and long bike rides ...
Cached Medicine News:Health News:Go Skateboarding Day 2010 Events Grow and Bring Skaters Together 2Health News:Go Skateboarding Day 2010 Events Grow and Bring Skaters Together 3Health News:Go Skateboarding Day 2010 Events Grow and Bring Skaters Together 4Health News:A new view of fossils: The behavior of ancient life forms 2Health News:Hospital Physician Partners and Lock Haven Hospital Announce New Emergency Department Partnership 2Health News:Hospital Physician Partners and Lock Haven Hospital Announce New Emergency Department Partnership 3Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:VA Maryland Health Care System's Summer Health Tips 2Health News:VA Maryland Health Care System's Summer Health Tips 3Health News:VA Maryland Health Care System's Summer Health Tips 4Health News:VA Maryland Health Care System's Summer Health Tips 5
Provides range-of-motion control for both flexion and extension along with a drop lock feature...
... Bledsoe Thruster 2 OA Knee Brace uses ... 2 Medial) or laterally (Thruster 2 Lateral) ... extension to help relieve pain for moderate ... arthrosis. For mild to moderate OA, Bledsoe ...
The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
... The Bledsoe Original Knee Brace gives ... For positive ROM control, this brace features ... extension and flexion from 0-120, and positively ... Designed with two eccentric cam slots, the ...
Medicine Products: